Karyopharm Therapeutics Inc. — Director's Dealing 2024

May 30, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Karyopharm Therapeutics Inc. (KPTI)
CIK: 0001503802
Period of Report: 2024-05-29

Reporting Person: Schor Chen (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-29	Nonstatutory Stock Option (right to buy)	$0.96	A	69000	Acquired	2034-05-28	Common Stock (69000)	Direct

Footnotes

F1: This option vests as to 100% of the underlying shares on May 29, 2025.